A Guide to Understanding Lectins vs Antibodies
In this blog post, we will explore IHC and IF techniques and how they have been used for identifying cancer biomarkers.
Insights from our team
Vector Laboratories’ blog provides a wealth of information on immunohistochemistry (IHC), immunofluorescence (IF), and related life science research topics.
Glycobiology
In Search of an Early-stage Detection Test for Parkinson’s Disease
As a part of Parkinson's Awareness Month, we are highlighting research being done for early stage detection.
Immunotherapy and Glycans
Learn all about the role of glycans in immunotherapy in this blog post.
Glycans and the tumor microenvironment
This article summarizes the considerations for using lectins in glycobiology assay workflows. Although many steps are identical to those in the antibody-integrated workflows, there are subtle but crucial differences.
The Role of Glycans in Colorectal Cancer Progression
As a part of Colorectal Cancer month, we will be highlighting research being done to progress treatment options.
How to use lectins in glycobiology workflows
This article summarizes the considerations for using lectins in glycobiology assay workflows. Although many steps are identical to those in the antibody-integrated workflows, there are subtle but crucial differences.
Everything We Know About Lectin Structure, Classification, and Function
In this blog post, we will be reviewing everything we know bout lectin structure, classification, and function.
An Introduction to the Universe of Glycans
Learn all about glycans, an important building block in many cellular processes.
Answering your questions: How to detect glycan expression in tissue
Dr. August Estabrook, Senior Scientist at Vector Laboratories answers questions from a recent webinar on the basics of glycan screening and how to use GlysiteTM Scout Glycan Screening Kits.
Breast Cancer Awareness Month: Impact of polysialylation in breast cancer outcomes
In this post we highlight a recent work from the University of British Columbia on the role of polySia, CD56, and polysialyltransferases in the breast tumor microenvironment.
